Medulloblastoma in children: A 32-year experience from a single institution

Journal of Neuro-Oncology

Volumn 90, Issue 1, 2008, Pages 99-103

  Akyüz, Canan ^a   Varan, Ali ^a   Küpeli, Serhan ^a   Akalan, Nejat ^a   Söylemezoglu, Figen ^a   Zorlu, Faruk ^a   Kutluk, Tezer ^a   Büyükpamukçu, Münevver ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Children; Medulloblastoma; Prognosis; Treatment

Indexed keywords

CISPLATIN; ETOPOSIDE; LOMUSTINE; PREDNISOLONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ARTICLE; BRAIN BIOPSY; BRAIN SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SPINAL CORD METASTASIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT; KAPLAN-MEIERS ESTIMATE; MALE; MEDULLOBLASTOMA; NEUROSURGICAL PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 50649125797     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9638-x     Document Type: Article

References (20)

1. Blaney SM, Kun LE, Hunter J et al (2006) Tumors of the central nervous system. In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 786-864
2. Eberhart CG, Chaudhry A, Daniel RW (2005) Increased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virus. BMC Cancer 5:19
3. Zeltzer PM, Boyett JM, Finlay JL et al (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17:832-845
4. Kleihues P, Cavenee WK (eds) (2000) Pathology and genetics of tumors of the nervous system: World Health Organization classification of tumors. IARC Press, Lyon
5. Polkinghorn WR, Tarbell NJ (2007) Medulloblastoma: Tumorigenesis, current clinical paradigm and efforts to improve risk stratification. Nat Clin Pract Oncol 4:295-304
6. Eberhart CG, Kepner JL, Goldthwaite PT et al (2002) Histopathologic grading of medulloblastomas. A pediatric oncology group study. Cancer 94:552-560
7. Bailey CC, Gnekow A, Wellek S et al (1995) Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 25:166-178
8. Jenkin D, Shabanah MA, Shail EA et al (2000) Prognostic factors for medulloblastoma. Int J Radiat Oncol Biol Phys 47:573-584
9. Weil MD, Lamborn K, Edwards MS et al (1998) Influence of a child's sex on medulloblastoma outcome. JAMA 279:1474-1476
10. Danjoux CE, Jenkin RDT, McLaughlin J et al (1996) Childhood medulloblastoma in Ontario, 1977-1987: Population based results. Med Pediatr Oncol 26:1-9
11. Gilbertson RJ, Jaros E, Perry RH et al (1997) Mitotic percentage index: a new prognostic factor for childhood medulloblastoma. Eur J Cancer 33:609-615
12. Urberuaga A, Navajas A, Burgos J, Pijoan JI (2006) A review of clinical and histological features of Spanish paediatric medulloblastomas during the last 21 years. Childs Nerv Syst 22:466-474
13. Varan A, Akalan N, Söylemezoǧlu F et al (2006) Central nervous system tumors in patients under three years of age: Treatment results of a single institute. Pediatr Neurosurg 42:89-94
14. Packer RJ, Sutton LN, Elterman R et al (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU and vincristine chemotherapy. J Neurosurg 81:690-698
15. Packer RJ, Goldwein J, Nicholson HS et al (1999) Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol 17:2127-2136
16. Padovani L, Sunyach MP, Perol D et al (2007) Common strategy for adult and pediatric medulloblastoma: A multicenter series of 253 adults. Int J Radiat Oncol Biol Phys 68:433-440
17. Delcharco JO, Bolek TW, McCollough WM et al (1998) Medulloblastoma: time-dose relationship based on a 30-year review. Int J Radiat Oncol Biol Phys 42:147-154
18. Prados MD, Edwards MSB, Chang SM et al (1999) Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a phase II study. Int J Radiat Oncol Biol Phys 43:279-285
19. Matsutani M (2004) Chemoradiotherapy for brain tumors: Current status and perspectives. Int J Clin Oncol 9:471-474
20. Kortmann RD, Kühl J, Timmermann B et al (2000) Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 46:269-279